43 results on '"Manesis E."'
Search Results
2. Keratin 7 expression in hepatic cholestatic diseases
3. Keratin 7 expression in hepatic cholestatic diseases (Jul, 10.1007/s00428-021-03152-z, 2021)
4. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers
5. Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study
6. Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study
7. Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
8. 2D-SHEAR WAVE ELASTOGRAPHY IS EQUIVALENT OR SUPERIOR TO TRANSIENT ELASTOGRAPHY FOR LIVER FIBROSIS ASSESSMENT: RESULTS FROM AN INDIVIDUAL PATIENT DATA BASED META-ANALYSIS
9. Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority Hepatitis B virus-resistant strains in the era of personalized medicine
10. HEPATOCELLULAR CARCINOMA (HCC) RISK IN HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe-) WITH OR WITHOUT CIRRHOSIS TREATED WITH ENTECAVIR: RESULTS OF THE NATIONWIDE HepNet.Greece COHORT STUDY
11. DETECTION OF MINORITY HBV RESISTANT STRAINS IN HBV TREATMENT NAIVE PATIENTS USING A HIGHLY SENSITIVE ASSAY BASED ON ARMS RT-PCR WITH MOLECULAR BEACON
12. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
13. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
14. Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology
15. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study
16. Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: A multicentre Greek study
17. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease
18. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis
19. Clinical evaluation of the arms RT-PCR for the quantitative detection of M204V variants in chronic HBV patients
20. Serum apoptotic caspase activity as marker of disease severity in chronic hepatitis C (CH-C) or non-alcoholic fatty liver disease (NAFLD)
21. Longitudinal changes in serum HBV-DNA levels during the natural course of HBeAg-negative chronic hepatitis B virus (HBV) infection
22. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: A comparative approach with genotype 1 chronic hepatitis C
23. HBeAg-negative chronic hepatitis B (CHBE-) in chronic HBV patients with serum HBV-DNA levels below 2,000 IU/mL
24. Liver involvement in acute vaso-occlusive crisis of patients with sickle cell disease: Prevalence and predisposing factors
25. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude
26. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B)
27. Assessment of depression in patients with chronic viral hepatitis: Effect of interferon treatment
28. Hadronic Energy-Flow in Leptoproduction - a Test of Qcd
29. Effects of Inclusive Dipole-Pomeron to Exclusive Processes
30. Double-Pomeron Exchange Cross-Sections with a Central 2-Pi Vertex
31. Qcd and Hadronic Energy-Flow at Sps and Hera Energies
32. Flavor and Baryon Quantum Numbers and Their Nondiffractive Re-Normalizations of Pomeron
33. CARCINOEMBRYONIC ANTIGEN IN THYROID DISEASE
34. Pp Total Cross-Section Rise with a Renormalized Pomeron
35. Orthocharmonium States from Generalized Vector Dominance
36. Scaling Violation in Electroproduction at Large Omega'
37. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
38. Serum apoptotic caspase activity as a marker of severity in chronic hepatitis C virus infection
39. Non-alcoholic fatty liver and cardiovascular disease: An emerging relationship
40. Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek nationwide cohort study
41. Flow-mediated vasodilation is decreased in non-alcoholic fatty liver disease and is associated with adiponectin levels
42. The burden and recent epidemiological changes of the chronic hepatitis B and C virus infections in a Greek referral tertiary center
43. Association of antiviral therapy with reduced disease progression in chronic hepatitis b patients: Results from a nation-wide cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.